AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:23 am Purchase |
2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 13,411,111 9.900% |
2,786,111 (+26.22%) |
Filing |
| 2023-02-14 09:36 am Purchase |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 10,625,000 9.600% |
2,069,445 (+24.19%) |
Filing |
| 2022-02-11 10:04 am Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 8,555,555 8.900% |
8,555,555 (New Position) |
Filing |